Drug & medication recalls High risk

Impax Laboratories, Inc. recalls Lamotrigine Orally Disintegrating Tablets (ODT), 200 mg, 30 Tablets 3 blisters containing 10 tablets each, Rx only, Man…

Recall date
August 19, 2016
Source
U.S. Food & Drug Administration (FDA) — enforcement report
Recall number
D-0215-2017
FDA classification
Class I
Brand / firm
Impax Laboratories, Inc.
Sold / distributed
Distributed Nationwide

Why it was recalled

Labeling; Label Mixup; box labeled to contain 200 mg blister packs but actually contain 100 mg blister packs

Class I is the FDA’s most serious recall level: there is a reasonable probability that using this product will cause serious harm or death.

What was recalled

Lamotrigine Orally Disintegrating Tablets (ODT), 200 mg, 30 Tablets 3 blisters containing 10 tablets each, Rx only, Manufactured by: Watson Pharma Private Ltd., Verna, Salcette Goa INDIA, Distributed by: Impax Generics, Hayward, CA

Get recall alerts

Free email alert whenever Impax Laboratories, Inc. has a new recall — straight from official government data. Unsubscribe anytime.

More recalls from: Impax Laboratories, Inc.